11:09 AM EST, 02/13/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were tracking slightly lower late Thursday morning, declining 0.04% to 1,402.70 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by pharmaceutical company Ascendis Pharma ( ASND ) and biotech company BioNTech (BNTX), which climbed 14.9% and 6.3% respectively. They were followed by biopharmaceutical company Grifols ( GRFS ) and biotech company and Evaxion Biotech ( EVAX ) , which rose 5.6% and 1.5% respectively.

The decliners from continental Europe were led by consumer goods company Unilever ( UL ) and pharmaceutical company Novo Nordisk ( NVO ) , which fell 5% and 3% respectively. They were followed by telecommunications company Nokia ( NOK ) and financial services company Banco Santander (SAN), which were off 0.5% each.

From the UK and Ireland, the gainers were led by biopharmaceutical company Amarin ( AMRN ) and pharmaceutical company Silence Therapeutics ( SLN ) , which increased 6.7% and 3.3% respectively. They were followed by alcoholic beverage company Diageo ( DEO ) and biopharmaceutical company NuCana ( NCNA ) , which were up 2.6% and 2.3% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company TC Biopharm ( TCBP ) and tobacco company British American Tobacco ( BTI ) , which shed 16.3% and 9.1% respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) and financial services company Barclays ( JJCTF ) , which were down 6.7% and 4.8% respectively.